Posters European Corner 2023

Nom i cognoms / Name and surname
Marc Suárez Calvet

Afiliació / Affiliation
BarcelonaBeta Brain Research Center

Programa de finançament europeu en que s’enmarca aquest projecte? / European funding programme in which this project is being carried out?
EU support (FP7, H2020, etc.) other than MSCA

Títol del projecte / Project title

Número del projecte / Project number

Breu explicació del projecte / Brief explanation of your project
The overall aim of the HeBe project is to identify circulating blood factors (i.e. proteins and metabolites) with a rejuvenating or an ageing effect on the human brain that can therefore become therapeutic targets for Alzheimer’s Disease (AD). Following the failure of many clinical trials of AD drug candidates, new therapeutic targets urgently need to be developed. The recent discovery of brain rejuvenating or ageing blood factors in animal models has created new opportunities to target age-related diseases like AD. However, there is currently no evidence that such factors have a similar effect on the human brain.
In HeBe, we will test the general hypothesis that humans also have rejuvenating or ageing circulating blood factors that affect brain health. We seek ultimately to answer the question whether modifying the levels of these blood factors in humans is a useful prevention and treatment strategy in the earliest asymptomatic stage of AD (preclinical AD).

Enllaç a la pàgina web del projecte / Link to your project website

Repte en que s’emmarca aquest projecte / Challenge within the framework of this project


Amb el suport de:

Amb el finançament de:

Aquest projecte està cofinançat pel programa de recerca i innovació Horizon Europe de la Unió Europea sota el projecte NitRecerCat (101061189).

This project is co-funded by the European Union’s research and innovation programme Horizon Europe, under the project NitRecercat (101061189).